Gangjun Du
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- Angiogenesis and VEGF in Cancer 2
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Haihong Lin (14 shared papers)Linlin Lu (4 shared papers)Lijuan Yu (3 shared papers)Guang Han (6 shared papers)Mei Wang (2 shared papers)Shuo Zhang (3 shared papers)Jiahuan Li (5 shared papers)Zhenzhen Guo (11 shared papers)
In The Last Decade
Gangjun Du
35 papers receiving 844 citations
Peers
Comparison fields: 5 of 92
- Toxicology 40
- Biochemistry 70
- Sensory Systems 48
- Molecular Medicine 45
- Pharmacology 69
Countries citing papers authored by Gangjun Du
This map shows the geographic impact of Gangjun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gangjun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gangjun Du more than expected).
Fields of papers citing papers by Gangjun Du
This network shows the impact of papers produced by Gangjun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gangjun Du. The network helps show where Gangjun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Gangjun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 115 | |
| 2 | 2010 | 63 | |
| 3 | 2009 | 62 | |
| 4 | 2013 | 46 | |
| 5 | 2008 | 46 | |
| 6 | 2019 | 38 | |
| 7 | 2019 | 37 | |
| 8 | 2018 | 35 | |
| 9 | 2016 | 35 | |
| 10 | 2004 | 32 | |
| 11 | 2022 | 31 | |
| 12 | 2013 | 29 | |
| 13 | 2022 | 25 | |
| 14 | 2007 | 25 | |
| 15 | 2013 | 25 | |
| 16 | 2021 | 25 | |
| 17 | 2013 | 21 | |
| 18 | 2005 | 19 | |
| 19 | 2020 | 18 | |
| 20 | 2013 | 17 |
About Gangjun Du
Gangjun Du is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 36 papers that have together received 865 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Immune cells in cancer (2 papers), Adipose Tissue and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Berberine and alkaloids research (2 papers), Ginger and Zingiberaceae research (2 papers) and Microbial Metabolism and Applications (2 papers). The work is most often cited by research in Toxicology (40 citations), Biochemistry (70 citations), Sensory Systems (48 citations), Molecular Medicine (45 citations) and Pharmacology (69 citations). Gangjun Du has collaborated with scholars based in China and Czechia. Frequent co-authors include Haihong Lin, Linlin Lu, Lijuan Yu, Guang Han, Mei Wang, Shuo Zhang, Jiahuan Li, Zhenzhen Guo, Weijie Liu and Shuo Zhang. Their work appears in journals such as International Immunopharmacology, Journal of Ethnopharmacology, European Journal of Pharmacology, Cancer Chemotherapy and Pharmacology and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.